Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Brigitte Sola; Roué G

doi:10.1158/1078-0432.ccr-13-1569

Journal articles

Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Moros A Bustany S Cahu J Saborit-Villarroya I Martínez A Colomer D Brigitte Sola ¹ Roué G

1 MILPAT - Microenvironnement cellulaire et pathologie

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-01762008
Contributor : Université Normandie <>
Submitted on : Monday, April 9, 2018 - 3:50:07 PM
Last modification on : Monday, July 1, 2019 - 3:08:08 PM

Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Links full text

Identifiers

Collections

Citation

Export

Metrics

71

Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

71